Pembrolizumab (pembro) as first-line therapy in elderly...

European Urology Supplements 2018 / 03 Vol. 17; Iss. 2

Pembrolizumab (pembro) as first-line therapy in elderly patients (pts) with poor performance status with cisplatin-ineligible advanced urothelial cancer (UC): Results from Keynote-052

Castellano, D., Grivas, P., Plimack, E., Balar, A., O’Donnell, P., Bellmunt, J., Powles, T., Hahn, N., De Wit, R., Bajorin, D., Ellison, M.C., Frenkl, T., Keefe, S., Vuky, J.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
17
Language:
english
Journal:
European Urology Supplements
DOI:
10.1016/S1569-9056(18)30938-2
Date:
March, 2018
File:
PDF, 86 KB
english, 2018
Conversion to is in progress
Conversion to is failed